Andrzej Kansy

Andrzej Kansy

Auto-generated profile, based on publicly available information

Andrzej Kansy

Pediatric Cardiothoracic Surgery, Children’s Memorial Health Institute , Warsaw

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
JRJoanna Rękawek
Joanna Rękawek
AKAndrzej Kansy
Andrzej Kansy
MMMaria Miszczak-Knecht
Maria Miszczak-Knecht
MMMałgorzata Manowska
Małgorzata Manowska
KBKatarzyna Bieganowska
Katarzyna Bieganowska
WKWanda Kawalec
Wanda Kawalec

1 April 2010 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
AKAndrzej Kansy
Andrzej Kansy
ZTZdzislaw Tobota
Zdzislaw Tobota
PMPrzemyslaw Maruszewski
Przemyslaw Maruszewski
BMBohdan Maruszewski
Bohdan Maruszewski

1 September 2005 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
BMBohdan Maruszewski
Bohdan Maruszewski
FLFrancois Lacour-Gayet
Francois Lacour-Gayet
JMJames L. Monro
James L. Monro
BKBruce E. Keogh
Bruce E. Keogh
ZTZdzislaw Tobota
Zdzislaw Tobota
AKAndrzej Kansy
Andrzej Kansy
The multi-national and multi-institutional collection of data on outcomes in Congenital Heart Surgery (CHS) provides the possibility of analysis of results of treatment and may result in further improvement of the quality of care. The verification of data as far as the completeness and accuracy is necessary to give confidence to all sides--the patients, centers and regulatory authorities. The source data verification (SDV), although difficult, appears possible even in such a large-scale database. Out of 5.274 patients and 5.612 procedures data of 2003, collected in the database, 1.703 (32.3%) and 1.895 (33.8%), respectively, have been verified at five sites on following fields: IPPV time, date of birth, date of admission, date of surgery, date of discharge/mortality, body weight, case category, CPB time, AoX time, Circulatory arrest time. SDV was performed at five sites by two database officers using the sources of information different to the local copy of the database (patients' files, operation notes, perfusion charts, OR Books). Verification was performed between June 1st and July 31st 2004. Statistical analysis was performed using R-project software, ver. 2.0.0. and Welch's t-test for comparison of continuous variables. P-value >0.05 was used as statistically significant difference between groups. Pre- and post-verification mortalities in all groups showed no significant differences although seven deaths out of 68 (10.27%) were missed. None of the other verified fields showed significant differences after verification. Source Data Verification showed no statistically significant differences between verified and non-verified data on 30 days mortality, LOS, age, body weight, CPB time, AoX and Circulatory arrest time. IPPV time was not available in 58.6% procedures.

23 April 2021 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
MJMarek J Jasinski
Marek J Jasinski
KKKinga Kosiorowska
Kinga Kosiorowska
RGRadoslaw Gocol
Radoslaw Gocol
JJJakub Jasinski
Jakub Jasinski
RNRafał Nowicki
Rafał Nowicki
MDMarek A Deja
Marek A Deja
This study presents the results of 17 years of experience with bicuspid aortic valve (BAV) repair and the analysis of factors associated with repair failure and early echocardiographic outcome. Between 2003 and 2020, a total of 206 patients [mean age: 44.5 ± 15.2 years; 152 males (74%)] with BAV insufficiency with or without aortic dilatation underwent elective aortic valve repair performed by a single surgeon with a mean follow-up of 5 ± 3.5 years. The transthoracic echocardiography examinations were reported. There were no deaths during the hospital stay, and all but 1 patient survived the follow-up period (99.5%). Overall, 10 patients (5%) developed severe insufficiency and 2 (1%) developed aortic dilatation requiring reoperation. Freedom from reoperation at 7 years reached 91.8%. Type 2 BAV configuration [hazard ratio (HR) 3.9; 95% confidence interval (CI): 1.01–60; P = 0.049], no sinotubular junction remodelling (HR 7; 95% CI: 1.7–23; P = 0.005), no circumferential annuloplasty (HR 3.9; 95% CI: 1.01–64; P = 0.047) and leaflet resection (HR 5.7; 95% CI 1.2–13. P = 0.017) have been identified as a risk factor of redo operation. Parameters of the postoperative left ventricle reverse remodelling improved significantly early after the operation and later at 2 years evaluation. The repair of BAV offers good short- and mid-term results providing a significant reverse left ventricular remodelling. Type 0 BAV preoperative configuration, circumferential annuloplasty and sinotubular junction remodelling are associated with better repair durability.

1 December 2012 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
AKAndrzej Kansy
Andrzej Kansy
JJJeffrey P. Jacobs
Jeffrey P. Jacobs
APAndrzej Pastuszko
Andrzej Pastuszko
MMMałgorzata Mirkowicz-Małek
Małgorzata Mirkowicz-Małek
MMMałgorzata Manowska
Małgorzata Manowska
BMBohdan Maruszewski
Bohdan Maruszewski

1 May 2019 in Surgical Infections
Verified
Journal Article
Closed access
Radoslaw JaworskiRadoslaw Jaworski
Radoslaw Jaworski
AKAndrzej Kansy
Andrzej Kansy
KDKatarzyna Dzierzanowska-Fangrat
Katarzyna Dzierzanowska-Fangrat
BMBohdan Maruszewski
Bohdan Maruszewski
Background: Prophylactic antibiotic therapy is given routinely in the peri-operative period to prevent surgical site infection. However, in pediatric cardiac surgery, an optimal schedule has not been defined. Pediatric recommendations follow the guidelines for adults, which might be improper because of the inherent challenges in pediatric research and the heterogeneity of the population. Implementation of an effective prophylaxis protocol is needed for children undergoing cardiac surgery, especially in view of worldwide antibiotic overuse and the development of drug resistance. In this review, we analyze the current knowledge supported by up-to-date publications about antibiotic prophylaxis in pediatric cardiac surgery. Methods: The PubMed® database was searched for full-text journal articles describing peri-operative antibiotic prophylaxis in pediatric cardiac surgery published since 2000. Antibiotics used for standard prophylaxis with dosing schema, time of the first dose, additional dosage in extracorporeal circulation (ECC) priming, and prophylaxis duration were analyzed. Additionally, we looked for special clinical situations such as antibiotic prophylaxis in children with the sternum left open after surgery and patients with β-lactam allergy or pre-operative methicillin-resistant Staphylococcus aureus (MRSA) colonization or those requiring extracorporeal membrane oxygenation (ECMO). Results: A total of 1,546 articles were evaluated, and we identified 20 for further analysis. On the basis of the current peri-operative antibiotic prophylaxis recommendations for cardiac surgery and the papers reviewed, we tried to propose a schedule for peri-operative antibiotic prophylaxis in pediatric cardiac surgery. Conclusions: There is a need for careful use and examination of the schedule proposed because the pharmacokinetics of antibiotics in pediatric patients with ECC is not fully understood. This should be evaluated further. Formulating uniform recommendations concerning peri-operative antibiotic prophylaxis is difficult.